For research use only. Not for therapeutic Use.
IMD-0354(CAT: I005720) is a potent and selective inhibitor of IKKβ (IκB kinase β), a critical regulator of the NF-κB signaling pathway. By inhibiting IKKβ, IMD-0354 blocks the activation of NF-κB, reducing the expression of pro-inflammatory cytokines and mediators. This compound is widely used in research to study inflammation, immune responses, and cancer, as NF-κB plays a pivotal role in these processes. IMD-0354 is a valuable tool for investigating NF-κB-driven pathways and for preclinical studies aimed at developing therapies for inflammatory diseases, autoimmune disorders, and cancer. Its high specificity and efficacy make it a reliable choice for targeted research.
Catalog Number | I005720 |
CAS Number | 978-62-1 |
Synonyms | IMD0354;IMD 0354; |
Molecular Formula | C15H8ClF6NO2 |
Purity | ≥95% |
Target | IKK |
Solubility | 10 mM in DMSO |
Storage | 3 years -20C powder |
IUPAC Name | N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide |
InChI | InChI=1S/C15H8ClF6NO2/c16-9-1-2-12(24)11(6-9)13(25)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6,24H,(H,23,25) |
InChIKey | CHILCFMQWMQVAL-UHFFFAOYSA-N |
SMILES | O=C(C1=C(O)C=CC(Cl)=C1)NC2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2 |